Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 801-808

  Chang, Julia W ^a,b   Coleman, Paul D ^a   O'Banion, M Kerry ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Box 603 ^*  (United States)

Author keywords

Astrocytes; GFAP; Gliosis; Hippocampus; Immunocytochemistry; In situ hybridization; Interleukin 1; Neocortex; Neurons

Indexed keywords

MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NEOCORTEX; PRIORITY JOURNAL;

EID: 0030250598     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00110-8     Document Type: Article

References (59)

1. 1. Abraham, C. A.; Selkoe, D. J.; Potter, H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501; 1988.
2. 2. Akiyama, H.; Kawamata, T.; Yamada, T.; Tooyama, I.; Ishii, T.; McGeer, P. L. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol. 85:628-634; 1993.
3. 3. Angerer, L. M.; Angerer, R. C. Localization of mRNAs by in situ hybridization. Methods Cell Biol. 35:37-71; 1991.
4. 4. Araujo, D. M.; Lapchak, P. A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors. Neuroscience 61:745-754; 1994.
5. 5. Aviv, H.; Leder, P. Purification of biologically active globin messenger RNA by chromatography on oligo-thymidilic acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408-1412; 1972.
6. 6. Breitner, J. C. S.; Gau, B. A.; Welsh, K. A.; Plassman, B. L.; McDonald, W. M.; Helms, M. J.; Anthony, J. C. Inverse association of antiinflammatory treatments with Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232; 1994.
7. 7. Breitner, J. C. S.; Welsh, K. A.; Helms, M. J.; Gaskell, P.C.; Gau, B. A.; Roses, A. D.; Pericak-Vance, M. A.; Saunders, A. M. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16:523-530; 1995.
8. 8. Callahan, L. M.; Selski, D. J.; Martzen, M. R.; Cheetham, J. E.; Coleman, P. D. Preliminary evidence: decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus. Neurobiol. Aging 15:381-386; 1994.
9. 9. Chirgwin, J. M.; Pryzbyla, A. E.; MacDonald, R. J.; Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299; 1979.
10. 10. Coleman, P. D.; Flood, D. G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8:521-545; 1987.
11. 11. Coleman, P.D.; Kazee, A.M.; Lapham, L.; Eskin, T.; Rogers, K. Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in frontal association cortex (area 9) in Alzheimer's disease. Neurobiol. Aging 13:631-639; 1992.
12. 12. Coleman. P. D.; Rogers, K. E.; Flood, D. G. Neuronal plasticity in normal aging and deficient plasticity in Alzheimer's disease: A proposed intercellular signal cascade. In: Coleman, P.; Higgins, G.; Phelps, C., eds. Progress in brain research. Amsterdam: Elsevier Science Publishers; 1990:75-87.
13. 13. DeKosky, S. T.; Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27:457-464; 1990.
14. 14. Dickson, D. W.; Lee, S. C.; Mattiace, L. A.; Yen, S.-H. C.; Brosnan, C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83; 1993.
15. 15. Eikelenboom, P.; Hack, C. E.; Rozemuller, J. M.; Stam, F. C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Archiv. B. Cell Pathol. 56:259-262; 1989.
16. 16. Feinberg, A. P.; Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13; 1983.
17. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812; 1995.
18. 18. Futaki, N.; Arai, I.; Hamasaka, Y.; Takahashi, S.; Higuchi, S.; Otomo, S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45:753-755; 1993.
19. 19. Garthwaite, J.; Boulton, C. L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:683-706; 1995.
20. 20. Graeber, M. B.; Streit, W. J.; Kreutzberg, G. W. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 21:18-24; 1988.
21. 21. Graham, S. H.; Nakayama, M.; Zhu, R.; Chen, J. Cyclooxygenase 2 and the pathogenesis of delayed neuronal death after global ischemia. Neurology 46:A408; 1996.
22. 22. Griffin, W. S. T.; Stanley. L. C.; Ling, C.; White, L.; MacLeod, V.; Perrot, L. J.; White, C. L., III; Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
23. 23. Hayaishi, O. Molecular mechanisms of sleep-wake regulation: Roles of prostaglandins D2 and E2. FASEB J. 5:2575-2581; 1991.
24. 24. Herschmann, H. R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13:241-256; 1994.
25. 25. Johnson, S. A.; Lampert-Etchells, M.; Pasinetti, G. M.; Rozovsky, I.; Finch, C. E. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13:641-648; 1992.
26. 26. Kaufmann, W. E.; Worley, P. F.; Pegg, J.; Bremer, M.; Isakson, P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 93:2317-2321; 1996.
27. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819; 1995.
28. 28. Kujubu, D. A.; Fletcher, B. S.; Varnum, B. C.; Lim, R. W.; Herschmann, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:12866-12872; 1991.
29. 29. Malmberg, A. B.; Yaksh, T. L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257:1276-1279; 1992.
30. 30. Malmberg, A. B.; Yaksh, T. L. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw foramalin injection: A microdialysis study in unanesthetized rats. J. Neurosci. 15:2768-2776; 1995.
31. 31. Mannoji, H.; Yeger, H.; Becker, L. E. A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology. Acta Neuropathol. 71:341-343; 1986.
32. 32. Masferrer, J. L.; Zweifel, B. S.; Manning, P. T.; Hauser, S. D.; Leahy, K. M.; Smith, W. G.; Isakson, P. C.; Seibert, K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91:3228-3232; 1994.
33. 33. McCarthy, K. D.; deVellis, J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890-902; 1980.
34. 34. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Activation of the classical complement pathway in brain tissue of Akheimer patients. Neurosci. Lett. 107:341-346; 1989.
35. 35. Narumiya, S. Prostanoid receptors: structure, function, and distribution. Ann. NY Acad. Sci. 744:126-138; 1994.
36. 36. Neary, D.; Snowden, J. S.; Mann, D. M. A.; Sims, N. R.; Northen, B.; Yates, P. O.; Davison, A. N. Alzheimer's disease: A correlative study. J. Neurol. Neurosurg. Psychol. 49:229-237; 1986.
37. 37. O'Banion, M. K.; Coleman, P. D.; Callahan, L. M. Regional neuronal loss in aging and Alzheimer's disease: A brief review. Semin. Neurosci. 6:307-314; 1994.
38. 38. O'Banion, M. K.; Miller, J. C.; Chang, J. W.; Kaplan, M. D.; Coleman, P. D. Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66:2532-2540; 1996.
39. 39. O'Banion, M. K.; Sadowski, H. B.; Winn, V.; Young, D. A. A serum-and glucocorticoid-regulated 4 kb mRNA encodes a cyclooxygenase related protein. J. Biol. Chem. 266:23261-23267; 1991.
40. 40. O'Banion, M. K.; Winn, V. D.; Young, D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89:4888-4892; 1992.
41. 41. Peppelenbosch, M. P.; Tertoolen, L. G. J.; Hage, W. J.; de Laat, S. W. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74:565-575; 1993.
42. 42. Potter, H. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease. Prog. Brain Res. 94:447-458; 1992.
43. 43. Pritchard, K. A., Jr.; O'Banion, M. K.; Miano, J. M.; Vlasic, N.; Bhatia, U. G.; Young, D. A.; Stemerman, M. B. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J. Biol. Chem. 269:8504-8509; 1994.
44. 44. Rivest, S.; Rivier, C. Centrally injected interleukin-1 beta inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats. J. Neuroendocrinol. 5:445-450; 1993.
45. 45. Robinson, A. P.; White, T. M.; Mason, D. W. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57:527-531; 1986.
46. 46. Rogers, J.; Kirby, L. C.; Hempelman, S. R.; Berry, D. L.; McGeer, P. L.; Kasznaik, A. W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Willson, P.; Kogan, F. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611; 1993.
47. 47. Rothwell, N. J. Eicosanoids, thermogenesis and thermoregulation. Prostaglandins Leukot. Essent. Fatty Acids 46:1-7; 1992.
48. 48. Salvemini, D.; Misko, T. P.; Masferrer, J. L.; Seibert, K.; Currie, M. G.; Needleman, P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90:7240-7244; 1993.
49. 49. Simmons, D. M.; Arriza, J. L.; Swanson, L. W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissue with radiolabeled single-stranded RNA probes. J. Histotechnol. 12: 169-181; 1989.
50. 50. Terry, R. D.; Masliah, E.; Salmon, D. P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L. A.; Katzman, R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:572-580; 1991.
51. 51. Terry, R. D.; Peck, A.; DeTeresa, R.; Schechter, R.; Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer's type. Ann. Neurol. 10:184-192; 1981.
52. 52. Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 231:232-235; 1971.
53. 53. Vane, J. R.; Mitchell, J. A.; Appleton, I.; Tomlinson, A.; Bishop-Bailey, D.; Croxtall, J.; Willoughby, D. A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91:2046-2050; 1994.
54. 54. Walker, D. G.; McGeer, P. L. Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14:109-116; 1992.
55. 55. Watanabe, T.; Morimoto, A.; Sakata, Y.; Murakami, N. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experienta 46:481-484; 1990.
56. 56. West, M. J.; Coleman, P. D.; Flood, D. G.; Troncoso, J. D. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772; 1994.
57. 57. Williams, J. H.; Bliss, T. V. An in vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arachidonic acid on the inauction and maintenance of long-term potentiation in the hippocampus. Neurosci. Lett. 107:301-306; 1989.
58. 58. Xie, W.; Chipman, J. G.; Robertson, D. L.; Erikson, R. L.; Simmons, D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA 88:2692-2696; 1991.
59. 59. Yamagata, K.; Andreasoon, K. I.; Kaufmann, W. I.; Barnes, C. A.; Worley, P. F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11:371-386; 1993.